期刊文献+

康莱特联合阿霉素诱导骨肉瘤细胞凋亡的实验研究 被引量:5

EXPERIMENTAL STUDY ON APOPTOSIS OF OSTEOSARCOMA CELLS INDUCED BY KANG-LAI-TE COMBINED WITH DOXORUBICIN
下载PDF
导出
摘要 目的研究康莱特对骨肉瘤细胞的诱导凋亡作用及其相关机制,探寻骨肉瘤的中西医结合化疗方案。方法免疫组化及RT-PCR方法检测不同浓度康莱特作用下骨肉瘤细胞的Fas表达,并将康莱特与阿霉素单独及联合应用于骨肉瘤细胞,采用MTT法检测细胞毒性作用,流式细胞仪定量分析凋亡细胞所占比例,倒置相差显微镜、荧光显微镜下观察凋亡细胞形态改变。结果康莱特可上调骨肉瘤细胞的Fas表达并诱导凋亡,康莱特浓度达到10μl/ml时,细胞抑制率不再明显改变,但如与1μlg/ml阿霉素合用将使细胞抑制率进一步提升(P<0.01)。细胞形态观察及凋亡率测定也显示,康莱特与阿霉素联用可诱导更多骨肉瘤细胞凋亡。结论康莱特可通过上调Fas表达诱导骨肉瘤细胞凋亡,康莱特与阿霉素合用可提高杀伤骨肉瘤细胞。 Objective To study the apoptosis of osteosarcoma cells induced by Kang-Lai-Te and the related mechanism so as to explore a new method of clinical chemotherapy. Methods Kang-Lai-Te and doxorubicin were applied on the osteosarcoma cells respectively or in combination. Immunohistochemistry and RT-PCR were used to examine the expression of Fas on the surface of the osteosarcoma cells, the inhi- bition rate was measured by MTT assay, the celluar shape was observed with inverted phase contrast microscope and fluorescence microscope, and the the apoptotic rate was analyzed with flow cytometry (FCM). Results Kang-Lai-Te had the effect of up-regulating the expression of Fas and inducing apoptosis. The inhibition rate was stagnated with more than 10μl/ml Kang-Lai-Te. However, if 10μl/ml Kang-Kai- Te was combined with 1 lg/ml doxorubicin, the inhibition rate was increased (P〈0. 01). Changes in cellular shape and apoptotic rate also indicated that the apoptosis-inducing effect of the combined application was much stronger than that of application alone. Conclusion Kang-Lai-Te can up-regulate Fas expression and induce cell apoptosis; Combination of Kang-Lai-Te and doxorubicin has a strong killing effect on osteosarcoma cells.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2005年第6期648-652,共5页 Chinese Journal of Histochemistry and Cytochemistry
关键词 康莱特 骨肉瘤 阿霉素 Kang-Lai-Te (KLT) Osteosarcoma Doxorubicin (DOX)
  • 相关文献

参考文献8

  • 1韩苏夏,朱青,杜蓓茹,杜兰.薏苡仁酯诱导人宫颈癌HeLa细胞凋亡的实验研究[J].肿瘤,2002,22(6):481-482. 被引量:35
  • 2王兆太,董光龙,王为忠.康莱特注射液对胃癌患者细胞凋亡、增殖及T细胞亚群的影响[J].细胞与分子免疫学杂志,2002,18(5):463-465. 被引量:9
  • 3杨树军,姚亚民,李玉富,孙红,马保根.康莱特注射液结合化疗治疗中晚期非小细胞肺癌的临床观察[J].中国中西医结合杂志,2003,23(8):629-629. 被引量:11
  • 4Iwase M, Watanabe H, Kondo G, et al. Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by doxorubicin and 5-fluorouracil. Int J Cancer, 2003,106(4):619-625.
  • 5Voelkel-Johnson C, King DL, Norris JS. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Cancer Gene Ther, 2002, 9(2): 164-172.
  • 6Song E, Chen J, Antus B , et al. Interleukin-2 enhances susceptibility of colon cancer cells to FasR mediated apoptosis by up-regulating Fas receptor level and down-regulating FAP-1 expression. Int J Immunopathol Pharmacol, 2000,13(3):113-122.
  • 7Lafleur EA, Jia SF, Worth LL, et al. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.Cancer Res,2001,61(10):4066-4071.
  • 8Wiedmann M, Tamaki S, Silberman R, et al. Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor. J Hepatol, 2003,38(6):803-810.

二级参考文献7

共引文献47

同被引文献69

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部